Tumor antigen presentation can be restored by epigenetic medications like DNA methylation and HDAC inhibitors, which increase the immune system's ability to recognize cancers and boost the effectiveness of checkpoint inhibitors. This evidence concerns the gene HDAC9 and cancer.